XLH rickets
Showing 1 - 25 of 81
Hypophosphatemia, Rickets, Hypercalciuria Trial in New Haven (phosphate)
Recruiting
- Hypophosphatemia
- +4 more
-
New Haven, ConnecticutYale University School of Medicine
May 17, 2022
X-linked Hypophosphatemia Trial in Würzburg (Burosumab)
Active, not recruiting
- X-linked Hypophosphatemia
-
Würzburg, GermanyClinical Trial Unit, Orthopedic Department, Wuerzburg University
Apr 26, 2022
Burden of Disease and Functional Impairment in XLH
Recruiting
- X Linked Hypophosphatemia
- no intervention
-
Wuerzburg, GermanyOrthopedic Center for Musculoskeletal Research, Orthopedic Depar
Aug 30, 2022
Characterising Pain, QoL, Body Composition, Arterial Stiffness,
Recruiting
- X-linked Hypophosphatemia
- Hereditary Hypophosphatemia
-
Aarhus N, DenmarkDept. of Endocrinology and Internal Medicine, The Osteoporosis C
Jan 14, 2022
X-Linked Hypophosphataemia Trial in United Kingdom
Recruiting
- X-Linked Hypophosphataemia
-
Glasgow, United Kingdom
- +3 more
Aug 30, 2022
X-linked Hypophosphatemia Disease Monitoring Program
Active, not recruiting
- X-linked Hypophosphatemia
- Hypophosphatemic Rickets
- No intervention
-
Birmingham, Alabama
- +38 more
Dec 7, 2022
X-linked Hypophosphatemia (XLH) Trial (adhesive system, fluoride varnish, flowable composite)
Not yet recruiting
- X-linked Hypophosphatemia (XLH)
- adhesive system
- +2 more
- (no location specified)
Apr 29, 2021
Quality of Life in XLH
Active, not recruiting
- X-linked Hypophosphatemia (XLH)
- None - Observational study
-
Oxford, United KingdomMedialis
Sep 11, 2020
Muscle Weakness, XLH Trial (MRI)
Not yet recruiting
- Muscle Weakness
- XLH
- MRI
- (no location specified)
Mar 28, 2022
Hypophosphatemia, Familial, Hyperparathyroidism Trial in New Haven (Paricalcitol, Placebo)
Completed
- Hypophosphatemia, Familial
- Hyperparathyroidism
- Paricalcitol
- Placebo
-
New Haven, ConnecticutYale University School of Medicine
Mar 3, 2020
X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration
Recruiting
- X-Linked Hypophosphatemia
- no intervention
-
Osaka, JapanOsaka University Hospital
Feb 9, 2022
X-linked Hypophosphatemia Trial in Worldwide (burosumab, Placebo)
Completed
- X-linked Hypophosphatemia
- burosumab
- Placebo
-
Los Angeles, California
- +24 more
Jan 15, 2021
X-linked Hypophosphatemia, Hypophosphatemic Rickets, Hypophosphatemic Rickets, X-Linked Dominant Trial in Boston (Calcitriol)
Recruiting
- X-linked Hypophosphatemia
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Mar 16, 2022
X-Linked Hypophosphatemia Trial in New Haven, Indianapolis, Saint Louis (Burosumab)
Completed
- X-Linked Hypophosphatemia
- Burosumab
-
New Haven, Connecticut
- +2 more
Mar 20, 2020
X-linked Hypophosphatemia Trial in New Haven (Burosumab Injection [Crysvita])
Completed
- X-linked Hypophosphatemia
- Burosumab Injection [Crysvita]
-
New Haven, ConnecticutYale University School of Medicine
Oct 7, 2022
Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS), Epidermal Nevus Syndrome Trial in Washington (Burosumab)
Active, not recruiting
- Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS)
- Epidermal Nevus Syndrome
-
Washington, District of ColumbiaChildren's National Hospital
Mar 4, 2022
X-Linked Hypophosphatemia Trial in Worldwide
Recruiting
- X-Linked Hypophosphatemia
-
Brussel, Belgium
- +115 more
Mar 29, 2022
Hypophosphatemic Rickets, X-Linked Dominant Trial in Kansas City (Cinacalcet)
Completed
- Hypophosphatemic Rickets, X-Linked Dominant
-
Kansas City, MissouriSection of Pediatric Nephrology, Children's Mercy Hospitals and
Jan 15, 2021
X-linked Hypophosphatemia Trial in Vienna (Foot X rays, Clinical examination + scores)
Completed
- X-linked Hypophosphatemia
- Foot X rays
- Clinical examination + scores
-
Vienna, AustriaOrthopedic Hospital Speising Vienna
Oct 5, 2023
X-Linked Hypophosphatemia Trial in United States (KRN23)
Completed
- X-Linked Hypophosphatemia
- KRN23
-
San Francisco, California
- +4 more
Nov 26, 2019